Source:http://linkedlifedata.com/resource/pubmed/id/18819469
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2008-9-29
|
pubmed:abstractText |
Apolipoprotein B mRNA-editing enzyme catalytic polypeptide 3 protein G (APOBEC3G) is part of the innate immune system of host cells and has cytidine deaminase activity. It specifically incorporates into the virion during HIV-1 replication. The incorporation of APOBEC3G needs its interaction with HIV-1 Gag. In the HIV-1 reverse transcription process, APOBEC3G deaminates dC to dU in the first minus strand cDNA, and then induces extensive hypermutation in the viral genome. Besides deamination, APOBEC3G also inhibits HIV-1 by some kinds of non-deamination mechanisms which need to be further elucidated. HIV-1 Vif counteracts the activity of APOBEC3G by an ubiquitin-proteasome-mediated degradation of APOBEC3G. As a broad spectrum inhibitor of viruses, APOBEC3G also inhibits various retroviruses, retrotransposons and other viruses like HBV. Upregulating the expression of APOBEC3G or blocking the Vif-mediated degradation of APOBEC3G might be novel strategies to treat HIV-1 infection in the future.
|
pubmed:grant | |
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0513-4870
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
43
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
678-82
|
pubmed:meshHeading |
pubmed-meshheading:18819469-Amino Acid Substitution,
pubmed-meshheading:18819469-Anti-HIV Agents,
pubmed-meshheading:18819469-Cytidine Deaminase,
pubmed-meshheading:18819469-Gene Expression,
pubmed-meshheading:18819469-HIV Infections,
pubmed-meshheading:18819469-HIV-1,
pubmed-meshheading:18819469-Humans,
pubmed-meshheading:18819469-Virus Replication,
pubmed-meshheading:18819469-vif Gene Products, Human Immunodeficiency Virus
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
|
pubmed:affiliation |
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|